184 related articles for article (PubMed ID: 8530497)
1. Novel tricyclic inhibitors of farnesyl protein transferase. Biochemical characterization and inhibition of Ras modification in transfected Cos cells.
Bishop WR; Bond R; Petrin J; Wang L; Patton R; Doll R; Njoroge G; Catino J; Schwartz J; Windsor W
J Biol Chem; 1995 Dec; 270(51):30611-8. PubMed ID: 8530497
[TBL] [Abstract][Full Text] [Related]
2. Effects of SCH 59228, an orally bioavailable farnesyl protein transferase inhibitor, on the growth of oncogene-transformed fibroblasts and a human colon carcinoma xenograft in nude mice.
Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Li Z; Dell J; Lipari P; Malkowski M; Prioli N; Rossman RR; Korfmacher WA; Nomeir AA; Lin CC; Mallams AK; Doll RJ; Catino JJ; Girijavallabhan VM; Kirschmeier P; Bishop WR
Cancer Chemother Pharmacol; 1999; 43(1):50-8. PubMed ID: 9923541
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Ha-ras, N-ras, Ki-Ras4A, and Ki-Ras4B as in vitro substrates for farnesyl protein transferase and geranylgeranyl protein transferase type I.
Zhang FL; Kirschmeier P; Carr D; James L; Bond RW; Wang L; Patton R; Windsor WT; Syto R; Zhang R; Bishop WR
J Biol Chem; 1997 Apr; 272(15):10232-9. PubMed ID: 9092572
[TBL] [Abstract][Full Text] [Related]
4. Substitution of cadmium for zinc in farnesyl:protein transferase alters its substrate specificity.
Zhang FL; Fu HW; Casey PJ; Bishop WR
Biochemistry; 1996 Jun; 35(25):8166-71. PubMed ID: 8679569
[TBL] [Abstract][Full Text] [Related]
5. The effect of the farnesyl protein transferase inhibitor SCH66336 on isoprenylation and signalling by the prostacyclin receptor.
O'Meara SJ; Kinsella BT
Biochem J; 2005 Feb; 386(Pt 1):177-89. PubMed ID: 15469414
[TBL] [Abstract][Full Text] [Related]
6. Farnesyl protein transferase inhibitors as potential cancer chemopreventives.
Kelloff GJ; Lubet RA; Fay JR; Steele VE; Boone CW; Crowell JA; Sigman CC
Cancer Epidemiol Biomarkers Prev; 1997 Apr; 6(4):267-82. PubMed ID: 9107432
[TBL] [Abstract][Full Text] [Related]
7. Posttranslational modification of Ha-ras p21 by farnesyl versus geranylgeranyl isoprenoids is determined by the COOH-terminal amino acid.
Kinsella BT; Erdman RA; Maltese WA
Proc Natl Acad Sci U S A; 1991 Oct; 88(20):8934-8. PubMed ID: 1924354
[TBL] [Abstract][Full Text] [Related]
8. Antitumor activity of SCH 66336, an orally bioavailable tricyclic inhibitor of farnesyl protein transferase, in human tumor xenograft models and wap-ras transgenic mice.
Liu M; Bryant MS; Chen J; Lee S; Yaremko B; Lipari P; Malkowski M; Ferrari E; Nielsen L; Prioli N; Dell J; Sinha D; Syed J; Korfmacher WA; Nomeir AA; Lin CC; Wang L; Taveras AG; Doll RJ; Njoroge FG; Mallams AK; Remiszewski S; Catino JJ; Girijavallabhan VM; Bishop WR
Cancer Res; 1998 Nov; 58(21):4947-56. PubMed ID: 9810004
[TBL] [Abstract][Full Text] [Related]
9. Discovery of novel nonpeptide tricyclic inhibitors of Ras farnesyl protein transferase.
Njoroge FG; Doll RJ; Vibulbhan B; Alvarez CS; Bishop WR; Petrin J; Kirschmeier P; Carruthers NI; Wong JK; Albanese MM; Piwinski JJ; Catino J; Girijavallabhan V; Ganguly AK
Bioorg Med Chem; 1997 Jan; 5(1):101-13. PubMed ID: 9043662
[TBL] [Abstract][Full Text] [Related]
10. Inhibitors of farnesyl protein transferase and MEK1,2 induce apoptosis in fibroblasts transformed with farnesylated but not geranylgeranylated H-Ras.
Brassard DL; English JM; Malkowski M; Kirschmeier P; Nagabhushan TL; Bishop WR
Exp Cell Res; 2002 Feb; 273(2):138-46. PubMed ID: 11822869
[TBL] [Abstract][Full Text] [Related]
11. Structure-activity relationship of 3-substituted N-(pyridinylacetyl)-4- (8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene )- piperidine inhibitors of farnesyl-protein transferase: design and synthesis of in vivo active antitumor compounds.
Njoroge FG; Vibulbhan B; Rane DF; Bishop WR; Petrin J; Patton R; Bryant MS; Chen KJ; Nomeir AA; Lin CC; Liu M; King I; Chen J; Lee S; Yaremko B; Dell J; Lipari P; Malkowski M; Li Z; Catino J; Doll RJ; Girijavallabhan V; Ganguly AK
J Med Chem; 1997 Dec; 40(26):4290-301. PubMed ID: 9435898
[TBL] [Abstract][Full Text] [Related]
12. Polylysine and CVIM sequences of K-RasB dictate specificity of prenylation and confer resistance to benzodiazepine peptidomimetic in vitro.
James GL; Goldstein JL; Brown MS
J Biol Chem; 1995 Mar; 270(11):6221-6. PubMed ID: 7890759
[TBL] [Abstract][Full Text] [Related]
13. Bisubstrate inhibitors of farnesyltransferase: a novel class of specific inhibitors of ras transformed cells.
Manne V; Yan N; Carboni JM; Tuomari AV; Ricca CS; Brown JG; Andahazy ML; Schmidt RJ; Patel D; Zahler R
Oncogene; 1995 May; 10(9):1763-79. PubMed ID: 7753553
[TBL] [Abstract][Full Text] [Related]
14. Natural inhibitors for protein prenyltransferase.
Lee S; Park S; Oh JW; Yang C
Planta Med; 1998 May; 64(4):303-8. PubMed ID: 9619109
[TBL] [Abstract][Full Text] [Related]
15. Phosphinyl acid-based bisubstrate analog inhibitors of Ras farnesyl protein transferase.
Patel DV; Gordon EM; Schmidt RJ; Weller HN; Young MG; Zahler R; Barbacid M; Carboni JM; Gullo-Brown JL; Hunihan L
J Med Chem; 1995 Feb; 38(3):435-42. PubMed ID: 7853336
[TBL] [Abstract][Full Text] [Related]
16. Identification of pharmacokinetically stable 3, 10-dibromo-8-chlorobenzocycloheptapyridine farnesyl protein transferase inhibitors with potent enzyme and cellular activities.
Taveras AG; Deskus J; Chao J; Vaccaro CJ; Njoroge FG; Vibulbhan B; Pinto P; Remiszewski S; del Rosario J; Doll RJ; Alvarez C; Lalwani T; Mallams AK; Rossman RR; Afonso A; Girijavallabhan VM; Ganguly AK; Pramanik B; Heimark L; Bishop WR; Wang L; Kirschmeier P; James L; Carr D; Liu M
J Med Chem; 1999 Jul; 42(14):2651-61. PubMed ID: 10411485
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of farnesyl protein transferase by monoterpene, curcumin derivatives and gallotannin.
Chen X; Hasuma T; Yano Y; Yoshimata T; Morishima Y; Wang Y; Otani S
Anticancer Res; 1997; 17(4A):2555-64. PubMed ID: 9252680
[TBL] [Abstract][Full Text] [Related]
18. Synthesis of isomeric 3-piperidinyl and 3-pyrrolidinyl benzo[5,6]cyclohepta[1,2-b]pyridines: sulfonamido derivatives as inhibitors of Ras prenylation.
Kelly J; Wolin R; Connolly M; Afonso A; James L; Kirshmeier P; Bishop WR; McPhail AT
Bioorg Med Chem; 1998 Jun; 6(6):673-86. PubMed ID: 9681133
[TBL] [Abstract][Full Text] [Related]
19. Specific isoprenoid modification is required for function of normal, but not oncogenic, Ras protein.
Cox AD; Hisaka MM; Buss JE; Der CJ
Mol Cell Biol; 1992 Jun; 12(6):2606-15. PubMed ID: 1375323
[TBL] [Abstract][Full Text] [Related]
20. Polyisoprenylation of Ras in vitro by a farnesyl-protein transferase.
Schaber MD; O'Hara MB; Garsky VM; Mosser SC; Bergstrom JD; Moores SL; Marshall MS; Friedman PA; Dixon RA; Gibbs JB
J Biol Chem; 1990 Sep; 265(25):14701-4. PubMed ID: 2203759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
